Dr. Changyu Zhu is an Associate Program Officer for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program. He helps to oversee a biomedical research grant portfolio that identifies and invests in promising therapies to delay and/or treat T1D.

Prior to joining Helmsley, Changyu was a postdoctoral researcher at Sloan Kettering Institute for Cancer Research studying cancer development and metastasis. He also conducted his doctoral thesis research at Columbia University, focusing on obesity-related metabolic diseases including fatty liver disease and diabetes.

Changyu earned a Bachelor of Science in Biology from Peking University in China, and obtained his Ph.D. degree from the Nutritional and Metabolic Biology Program from Columbia University in New York. Outside of work, Changyu enjoys exploring different types of cuisine, and watching sci-fi and fantasy tv shows and movies.